ID: ALA3144548

Max Phase: Preclinical

Molecular Formula: C46H57N7O11

Molecular Weight: 884.00

Molecule Type: Small molecule

Representations

Canonical SMILES:  COc1ccc(/C=C\C(=O)NCCCC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)cc1OC

Standard InChI:  InChI=1S/C46H57N7O11/c1-46(2,3)64-45(61)53-35(25-30-27-49-32-16-10-9-15-31(30)32)43(59)50-33(17-11-12-22-48-39(54)21-19-29-18-20-37(62-4)38(24-29)63-5)42(58)52-36(26-40(55)56)44(60)51-34(41(47)57)23-28-13-7-6-8-14-28/h6-10,13-16,18-21,24,27,33-36,49H,11-12,17,22-23,25-26H2,1-5H3,(H2,47,57)(H,48,54)(H,50,59)(H,51,60)(H,52,58)(H,53,61)(H,55,56)/b21-19-/t33-,34-,35-,36-/m0/s1

Standard InChI Key:  OMBMAJUHTNLCKP-RNVWWRIPSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 884.00

Molecular Weight (Monoisotopic): 883.4116

AlogP: 3.28

#Rotatable Bonds: 23

Polar Surface Area: 269.37

Molecular Species: ACID

HBA: 10

HBD: 8

#RO5 Violations: 2

HBA (Lipinski): 18

HBD (Lipinski): 9

#RO5 Violations (Lipinski): 3

CX Acidic pKa: 4.06

CX Basic pKa:

CX LogP: 3.00

CX LogD: -0.13

Aromatic Rings: 4

Heavy Atoms: 64

QED Weighted: 0.04

Np Likeness Score: -0.07

References

1. Shiosaki K, Lin CW, Kopecka H, Craig RA, Bianchi BR, Miller TR, Witte DG, Stashko M, Nadzan AM..  (1992)  Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residues.,  35  (11): [PMID:1375964] [10.1021/jm00089a010]

Source

Source(1):

• Scientific Literature